RxDoctor Payments Data

Lacie Gregory, MD

Family Medicine · Wellington, KSNPI 1124223649

Payments from drug & device makers

$935in general payments, 2019–2025

Across 70 payments — averaging $13.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$206
  • Amgen$146
  • AstraZeneca$62
  • Lilly USA, LLC$57
  • Johnson & Johnson$56
  • Merck$48
  • plus $359 from 15 others

What the payments were for

  • Food & beverage$935100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$935 in reported general payments places this provider in the 60th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$3,445
Medicare patients
65
Services billed
233

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide117$121,685
EliquisApixaban94$75,767
MounjaroTirzepatide43$41,917
JanuviaSitagliptin Phosphate37$35,177
JardianceEmpagliflozin22$34,097
MyrbetriqMirabegron53$29,104
TrulicityDulaglutide16$22,975
Janumet XrSitagliptin Phos/Metformin Hcl14$18,676
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$14,455
SymbicortBudesonide/Formoterol Fumarate44$11,238
Nurtec OdtRimegepant Sulfate11$10,882
Synjardy XrEmpagliflozin/Metformin Hcl15$9,361
ExelonRivastigmine12$8,922
Insulin Lispro Kwikpen U-100Insulin Lispro23$8,264
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog15$8,189

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$206$121,685117 claims
PfizerEliquis, Nurtec Odt$45$86,649105 claims
Lilly USA, LLCMounjaro, Trulicity$57$64,89159 claims
MerckJanuvia, Janumet Xr$48$53,85351 claims
Astellas Pharma US IncMyrbetriq$27$29,10453 claims
GSKTrelegy Ellipta$24$14,45522 claims
AstraZenecaSymbicort$62$11,23844 claims
NovartisExelon$15$8,92212 claims
AbbVieSynthroid$36$2,05027 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,469 family medicine providers in Kansas.

Other family medicine in Wellington

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →